Beyond dengue: arbovirus surveillance and laboratory diagnostic strategies in Panama

Main Article Content

Stephany Young Yusty
Gilberto A Eskildsen

Abstract

Dengue is the most important arboviral disease in Panama and represents a growing challenge for epidemiological surveillance, diagnosis, and public health response. This narrative review describes the historical and epidemiological evolution of dengue in the country, as well as the development of virological surveillance and laboratory diagnostic strategies. Official epidemiological reports from the Ministry of Health, national regulatory documents, and peer-reviewed scientific literature retrieved through searches of PubMed, Scopus, and Google Scholar were integrated. Following the reinfestation by Aedes aegypti in 1985 and confirmation of the first autochthonous case in 1993, Panama experienced recurrent epidemics and the successive or simultaneous circulation of all four dengue virus serotypes. The epidemiological situation reached critical levels between 2023 and 2025: in 2024, 32,077 cases, 252 severe cases, and 52 deaths were confirmed. Concurrently, the introduction of chikungunya and Zika and the re-emergence of Oropouche virus increased the complexity of differential diagnosis. Diagnostic capacity evolved from a centralized model at the Gorgas Memorial Institute for Health Studies to a national network coordinated with the Ministry of Health, incorporating decentralized serological testing, molecular platforms at strategic sites, and genomic surveillance. The current national algorithm prioritizes RT-PCR or NS1 antigen detection during the acute phase and IgM/IgG serology during the convalescent phase, followed by the sequential investigation of other arboviruses. Panama has substantial laboratory capacity for dengue surveillance; however, the proportion of laboratory-confirmed cases varies by reporting period and should be presented with an explicit denominator and source.Panama has substantial laboratory capacity for dengue surveillance; however, the proportion of laboratory-confirmed cases varies by reporting period and should be presented with an explicit denominator and source. 

Downloads

Download data is not yet available.

Article Details

Section

Artículos originales

Author Biographies

Stephany Young Yusty, Universidad de Panamá

Magíster en Ciencias Biomédicas, Especialidad en Microbiología Médica. Departamento de Microbiología Humana, Facultad de Medicina, Universidad de Panamá. 

Gilberto A Eskildsen, Universidad de Panamá

Doctorado en Biotecnología con especialización en Virología. Departamento de Microbiología Humana, Facultad de Medicina, Universidad de Panamá.

How to Cite

1.
Beyond dengue: arbovirus surveillance and laboratory diagnostic strategies in Panama . Rev med caja seguro soc [Internet]. 2025 Oct. 2 [cited 2026 Nov. 10];45(1 - 3). Available from: https://revistamedicacss.edu.pa/rmcss/article/view/93

References

de Almeida MT, Merighi DGS, Visnardi AB, Boneto Gonçalves CA, Amorim VM de F, Ferrari AS de A, et al. Latin America’s dengue outbreak poses a global health threat. Viruses. 2025;17:57.

2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504–7.

3. Arrubla Hoyos WDJ. Conceptualización del diagnóstico del Dengue desde una perspectiva de la ingeniería y las nuevas tecnologías. CESTA. 2022;3:1–8.

4. Navarro Valencia V, Díaz Y, Pascale JM, Boni MF, Sanchez-Galan JE. Assessing the effect of climate variables on the incidence of dengue cases in the Metropolitan Region of Panama City. Int J Environ Res Public Health. 2021;18:12108.

5. Organización Panamericana de la Salud / Organización Mundial de la Salud. Guías para el abordaje integral del dengue en Panamá, 2014. OPS/OMS, Representación en Panamá. 2014 [cited 2026 Feb 18]. Disponible en: https://www.hospitalsantotomas.gob.pa/download/transparencia/otros_documentos_y_normas/OTROS-GUIA-DENGUE-ALTA.pdf

6. Chen-Germán M, Araúz D, Aguilar C, Vega M, Gonzalez C, Gondola J, et al. Detection of dengue virus serotype 4 in Panama after 23 years without circulation. Front Cell Infect Microbiol. 2024;14:1467465.

7. Armien B, Suaya JA, Quiroz E, Sah BK, Bayard V, Marchena L, et al. Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg. 2008;79:364–71.

8. Segura Benedicto A. Las dimensiones de la Salud Pública: una introducción. Revista de Gobierno Administración y Políticas de Salud. 2024;3:1.

9. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.

10. Carpenter DN. Dengue in the isthmian canal zone. Including a report on the laboratory findings. JAMA. 1905;XLIV:214.

11. Brathwaite Dick O, San Martín JL, Montoya RH, del Diego J, Zambrano B, Dayan GH. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg. 2012;87:584–93.

12. Rush B. An account of the bilious remitting yellow fever, as it appeared in the city of Philadelphia, in the year 1793 - Digital Collections - National Library of Medicine. [cited 2025 Aug 20]. Disponible en: https://collections.nlm.nih.gov/catalog/nlm:nlmuid-2569009R-bk

13. Ehrenkranz NJ, Ventura AK, Cuadrado RR, Pond WL, Porter JE. Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems. N Engl J Med. 1971;285:1460–9.

14. Hays I. On dengue. Am J Med Sci. 1828;2:459-67.

15. Gorgas WC. Sanitary conditions as encountered in Cuba and Panama, and what is being done to render the canal zone healthy. Medical Record 67. 1905;361-3.

16. Reed W. Recent researches concerning the etiology, propagation, and prevention of yellow fever, by the United States army commission. J Hyg (Lond). 1902;2:101–19.

17. Rosen L. Observations on the epidemiology of dengue in Panama. Am J Hyg. 1958;68:45–58.

18. Nelson M. AEDES AEGYPТІ: BIOLOGIA Y ECOLOGIА. Organización Panamericana de la Salud (OPS). 1986;1–62. Available from: https://iris.paho.org/bitstream/handle/10665.2/28513/PNSP8663_spa.pdf?sequence

19. Pan American Health Organization. CD1.R1: Continental Aedes Aegypti eradication. 1947. Disponible en: https://iris.paho.org/handle/10665.2/1733

20. Organización Panamericana de la Salud (OPS). Control y erradicación del Aedes aegypti. 1985;1–24. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/6721/26037.pdf?sequence=1&isAllowed=y

21. Quiroz E, Ortega M, Guzmán MG, Vázquez S, Pelegrino JL, Campos C, et al. Dengue in Panama, 1993. Rev Cubana Med Trop. 1997;49:86–93. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9685969/

22. Ministerio de Salud (Panamá), Dirección General de Salud, Departamento de Epidemiología. Dengue en Panamá, 1993. Boletín Epidemiológico. Panamá: MINSA; 1997.

23. Díaz Y, Chen-Germán M, Quiroz E, Carrera JP, Cisneros J, Moreno B, et al. Molecular epidemiology of dengue in Panama: 25 years of circulation. Viruses. 2019;11:764.

24. Whiteman A, Desjardins MR, Eskildsen GA, Loaiza JR. Detecting space-time clusters of dengue fever in Panama after adjusting for vector surveillance data. bioRxiv. 2019; 561902.

25. García L. Situación Epidemiológica del Dengue, Año 2013-2014. Ministerio de Salud de Panamá, Dirección General de Salud; 2014. Disponible en: https://www.gorgas.gob.pa/wp-content/uploads/2014/09/Dengue-EPIDEMIOLOGIA-18-8-2014.pdf

26. Cerezo L. Informe Epidemiológico Semanal de Dengue. Semana epidemiológica No. 52. Ministerio de Salud - República de Panamá, Dirección General de Salud Pública. Departamento Nacional de Epidemiología. 2024;1–20. Disponible en: https://www.minsa.gob.pa/sites/default/files/publicacion-general/informe_de_dengue_se52-de_vf.pdf

27. Ministerio de Salud (MINSA). BOLETÍN EPIDEMIOLÓGICO SEMANAL. Año: 2025. Semana 53. Dirección General de Salud Pública. Departamento Nacional de Epidemiología; 2026. Disponible en: https://www.minsa.gob.pa/sites/default/files/publicacion-general/boletin_epidemiologico_semanal_53_2025_v1.pdf

28. Ministerio de Salud de Panamá (MINSA). Oropouche en Panamá Boletín Epidemiológico No. 9 Año 2024 - 2025. Semana epidemiológica 15. Dirección General de Salud Pública, Departamento de Epidemiología. 2025;1–7.

29. Eskildsen GA, Kramer LD, Zink SD, Dupuis AP, Wong SJ, Furuya A, et al. Integrated arbovirus surveillance improves the detection onset of Zika virus in Panama. Am J Trop Med Hyg. 2020;102:985–7.

30. Anand A, Verma A, Khatib MN, Zahiruddin QS, Gaidhane S, Sharma RK, et al. An urgent call for action: addressing the unprecedented rise in dengue cases in the Americas. Ann Med Surg (Lond). 2024;86:3814–5.

31. Dutary BE, Rozette JE, Campos C. Current situation of the Aedes aegypti mosquito in the metropolitan area of Panama city. Rev Med Panama. 1989;14:67–78.

32. Wilson AL, Courtenay O, Kelly-Hope LA, Scott TW, Takken W, Torr SJ, et al. The importance of vector control for the control and elimination of vector-borne diseases. PLoS Negl Trop Dis. 2020;14:e0007831.